leadf
logo-loader
viewMountain Valley MD Holdings Inc
(
CSE:MVMDOTCQX:MVMDF
)

Mountain Valley MD stock uplists to the OTCQX Best Market as it eyes US senior exchange listing

Mountain Valley MD shares will begin trading on the OTCQX Best Market under the symbol ‘MVMDF’ effective August 27, 2021

Mountain Valley MD Holdings Inc -
Mountain Valley MD also said it has taken steps to evaluate a listing on either the New York Stock Exchange or NASDAQ

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) has announced that it shares will graduate from the OTCQB Venture Market and begin trading on the OTCQX Best Market under the symbol ‘MVMDF’ effective August 27, 2021.

Mountain Valley said graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors.

“We continue to pursue advancements that will provide a large US investor base with the opportunity to participate directly in our growth,” Mountain Valley MD Holdings CEO Dennis Hancock said in a statement.

READ: Mountain Valley MD Holdings says its Quicksome technology could change vaccine landscape after cold chain tests

“Trading on OTCQX will contribute to our strategy to continue to enhance our share liquidity and broaden the reach and awareness of our global health and wellness innovations,” Hancock added.

The company noted that its common share will continue to trade on the Canadian Securities Exchange under the ticker symbol ‘MVMD’ and the Frankfurt Stock Exchange under the ticker symbol ‘20MP’.

As well, Mountain Valley MD said has taken steps to evaluate a listing on either the New York Stock Exchange or NASDAQ and anticipates finalizing its strategy in the fourth quarter of 2021.

Mountain Valley MD is building a world-class biotech and life sciences company organization centered around the implementation of its patented Quicksome oral drug formulation and delivery technologies and its Quicksal. solubilization technology for macrocyclic lactones, to innovate industry-leading products that are sought out globally.

Contact Sean at sean@proactiveinvestors.com

Quick facts: Mountain Valley MD Holdings Inc

Follow
CSE:MVMD

Price: 0.29 CAD

Market Cap: $95.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Mountain Valley MD preparing to start pre-clinical trials for use of...

Mountain Valley MD (CSE: MVMD- OTCQB: MVMDF) CEO Dennis Hancock and Director of Life Sciences Mike Farber joined Steve Darling from Proactive to bring news the company has filed a cancer patent for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad...

on 4/5/21

2 min read